Cosmax Nbt Inc (222040) fair value: what the stock is really worth
As of Sep 23, 2026: fair value of Cosmax Nbt Inc KRW 4,772, price KRW 7,510, upside -36.5%, quality 43 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Cosmax Nbt Inc for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range 2,935 KRW – 12,700 KRW · fair‑value band 2,968 KRW – 7,379 KRW · the 7,510 KRW price screens above the 4,772 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. Dashed = 300-day average. As of Sep 24, 2026.
Follow Cosmax Nbt in your weekly email
Every Wednesday you see whether Cosmax Nbt is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Cosmax Nbt, Inc. operates as a health functional food company in South Korea and internationally. It also provides original design and original brand manufacturing services. In addition, the company offers cosmetics, medicines, and medical supplies. It offers its products in tablets, capsules, liquid, and powder supplement form of dosages.
Show more
Cosmax Nbt, Inc. operates as a health functional food company in South Korea and internationally. It also provides original design and original brand manufacturing services. In addition, the company offers cosmetics, medicines, and medical supplies. It offers its products in tablets, capsules, liquid, and powder supplement form of dosages. The company serves its products through business to business, distribution companies, pharmaceutical and food companies, networks, and online channels. Cosmax Nbt, Inc. was founded in 2002 and is headquartered in Seongnam-si, South Korea.
Stock analysis
Cosmax Nbt Inc (222040) currently trades at 7,510 KRW, while our model-based Fair Value estimate is 4,772 KRW, implying the stock looks roughly 57.4% overvalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of 10,348 KRW per share, and 6 of the 13 models we run sit above the 7,510 KRW price.
Bear case: the Asset-Based group reads lowest at 1,442 KRW, and 7 of the 13 models stay below the price. Evidence for this calculation is low.
Scenario range: 2,968 KRW (bear) to 7,379 KRW (bull), the price of 7,510 KRW sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 43/100 (below-average quality), in the Consumer Defensive sector.
Weak Growth: Growth has flattened: the last year, three and five years all grew more slowly than the long-term average.
Cosmax Nbt Inc reported revenue of 287B KRW in FY2025 versus 289B KRW in FY2021, a compound −0.2%/yr. Reported net income was −15.0B KRW in FY2025.
Key figures
Market cap 154B KRW (≈ $113M) · P/S ratio 0.52 · Net margin −5.2% · Return on equity −6.0% · Return on assets (EBIT) 2.1% · Operating margin 11.0% · Revenue (TTM) 309B KRW · Revenue growth (YoY) +29.2%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 37 out of 100 (medium confidence).
What moves the price
The share trades about 30% below its 52-week high and 154% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Consumer Defensive peers we cover trades at −3% fair-value upside, at −36%, 222040 screens richer than that median.
Fair Value models
Bear 2,968 KRWFair Value 4,772 KRWBull 7,379 KRW
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.26/100
Growth has flattened: the last year, three and five years all grew more slowly than the long-term average.
Revenue growth 1 year
−9.6%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−4.3%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+1.5%
Start year 2020 (pandemic). Over 10 years: +14.0% a year
Revenue growth 11 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+17.9%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−0.9% (2020) → 1.4% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+24.5%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (South Korea: IMF forecast 2.1% a year to 2030, 2.1% from 2016 to 2025) that is about +22.0% a year for the price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Packaged Foods · 668 stocks
Beats the industry median on 4/8 measures
A mixed picture versus its industry peers.
Valuation
Quality Score43 · Bottom 25%
Fair Value upside−37% · Below median
Profitability
Return on assets3% · Below median
Net margin (TTM)−1% · Bottom 25%
Operating margin (TTM)11% · Above median
Growth and dividend
Revenue growth29% · Top 25%
Balance sheet
Debt / equity0.03× · Below median
Valuation Multiplesvs Packaged Foods median · lower = cheaper
P/FCF0.0× · Cheapest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 31
FUTURE (revenue growth)100· sector 20
PAST (return on equity)0· sector 29
HEALTH (low debt)99· sector 96
DIVIDEND (yield)0· sector 58
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Cosmax Nbt Inc (222040) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 4,772 KRW versus a price of 7,510 KRW, about −36% upside (overvalued).
What is the fair value of 222040?
Our model-based fair value for Cosmax Nbt Inc is 4,772 KRW (as of Sep 24, 2026), built from audited fundamentals. The current price: 7,510 KRW.
What is the quality score of 222040?
Cosmax Nbt Inc has a Quality Score of 43/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Cosmax Nbt Inc (222040)?
Our model-based price target is the fair value of 4,772 KRW (as of Sep 24, 2026) from 13 valuation models. Cautious scenario 2,968 KRW, optimistic scenario 7,379 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the Cosmax Nbt Inc stock forecast for 2026?
Our models put fair value at 4,772 KRW, about −36% upside versus a price of 7,510 KRW (overvalued). Cautious scenario 2,968 KRW, optimistic scenario 7,379 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of Cosmax Nbt Inc (222040)?
Cosmax Nbt Inc reported trailing-twelve-month revenue of about 309B KRW (latest available figure, as of Sep 24, 2026).
What growth is priced into Cosmax Nbt Inc (222040)?
For today's price to be fair in a discounted-cash-flow model, Cosmax Nbt Inc would have to grow free cash flow by +24.5 % per year for five years (discount rate 12.9 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +1.5 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of 222040 use?
Our models discount Cosmax Nbt Inc at 12.9 %: a base by market capitalisation (micro), damped by beta 0.92, country premium for South Korea. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Cosmax Nbt Inc that is +24.5 % per year a year over ten years, using the same discount rate (12.9 %) and the same formula as our fair value.
How much growth has Cosmax Nbt Inc (222040) delivered so far?
Over the past 5 years revenue at Cosmax Nbt Inc grew +1.5 % a year. The price currently implies +24.5 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Cosmax Nbt Inc (222040) growing?
The median revenue growth in the sector is +2.9 % a year. That is the yardstick for the growth priced into Cosmax Nbt Inc (+24.5 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Cosmax Nbt Inc (222040)?
The free-cash-flow yield on the price is 6.08 %: that much free cash flow Cosmax Nbt Inc produces per unit of market value. When it exceeds the discount rate of our models (12.9 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Cosmax Nbt Inc (222040)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Cosmax Nbt Inc it is 4,772 KRW per share (as of Sep 24, 2026), against a price of 7,510 KRW. It is the blended result of 13 valuation models (cash flow, earnings, asset, dividend).
Is Cosmax Nbt Inc stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 222040 trades above its calculated fair value: price 7,510 KRW, fair value 4,772 KRW, a gap of about −36% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 222040?
No. The price is what the market pays today (7,510 KRW); the fair value is what the company's own numbers justify (4,772 KRW). For Cosmax Nbt Inc the two are 2,738 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is Cosmax Nbt Inc worth?
The market values Cosmax Nbt Inc at about 154B KRW (market capitalisation, as of Sep 24, 2026). Per share that is 7,510 KRW; our models calculate a fair value of 4,772 KRW per share.
What do the bullish and bearish scenarios say about 222040?
Our models span a range for Cosmax Nbt Inc: cautious scenario 2,968 KRW, base 4,772 KRW, optimistic 7,379 KRW per share (as of Sep 24, 2026, price 7,510 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Cosmax Nbt Inc (222040)?
Balance-sheet figures for Cosmax Nbt Inc (as of Sep 24, 2026): return on equity −6.0%, debt of 0.03 per unit of equity. They feed the Quality Score of 43/100, which measures business quality independently of the share price.
How far is 222040 from its 52-week high?
Cosmax Nbt Inc trades at 7,510 KRW, about 30% below its 52-week high of 10,700 KRW and 154% above the low of 2,960 KRW (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of 4,772 KRW is for.
Which stocks are comparable to Cosmax Nbt Inc?
From the same area (Consumer Defensive) we also value Nestlé S.A, Danone S.A, The Kraft Heinz Company, Foshan Haitian Flavouring and Food Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Cosmax Nbt Inc stock attractive at the current price?
The data as of Sep 24, 2026: price 7,510 KRW, calculated fair value 4,772 KRW (−36%), Quality Score 43/100, from 13 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 222040 calculated?
We run Cosmax Nbt Inc through 13 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 4,772 KRW, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.0 % above its aggregate fair value. Cosmax Nbt Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Cosmax Nbt Inc (222040)?
The closing price on Sep 23, 2026 was 7,510 KRW. Our model-based fair value is 4,772 KRW, about −36% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Cosmax Nbt Inc right now?
Weak quality (43/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range (2,968 KRW to 7,379 KRW) leaves room in how you read the outcome.
Key figures of Cosmax Nbt Inc
How large is the market capitalisation of Cosmax Nbt Inc (222040)?
The market capitalisation of Cosmax Nbt Inc is 154B KRW (≈ $113M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Cosmax Nbt Inc (222040)?
The price-to-sales ratio of Cosmax Nbt Inc is 0.52 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of Cosmax Nbt Inc (222040)?
The net margin of Cosmax Nbt Inc is −5.2% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Cosmax Nbt Inc (222040)?
The return on equity (ROE) of Cosmax Nbt Inc is −6.0% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Cosmax Nbt Inc (222040)?
On an EBIT basis the return on assets of Cosmax Nbt Inc is 2.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Cosmax Nbt Inc (222040)?
The operating margin of Cosmax Nbt Inc is 11.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Cosmax Nbt Inc (222040)?
Revenue at Cosmax Nbt Inc is growing +29.2% versus a year earlier (3y avg −4.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much net debt does Cosmax Nbt Inc (222040) carry?
The net debt of Cosmax Nbt Inc is 116B KRW (fiscal year 2025, ≈ 12.4 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Cosmax Nbt Inc in the live analysis
One click puts Cosmax Nbt Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
